• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲帕金森病患者血脑屏障转运体MDR1编码单核苷酸多态性的基因分析。

Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.

作者信息

Funke Claudia, Soehn Anne S, Tomiuk Juergen, Riess Olaf, Berg Daniela

机构信息

Department of Medical Genetics, University of Tuebingen, Tuebingen, Germany.

出版信息

J Neural Transm (Vienna). 2009 Apr;116(4):443-50. doi: 10.1007/s00702-009-0196-y. Epub 2009 Mar 3.

DOI:10.1007/s00702-009-0196-y
PMID:19255821
Abstract

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons and the presence of intracytoplasmic inclusions (Lewy bodies). Iron, which is elevated in the substantia nigra of PD patients, seems to be of pivotal importance, because of its capacity to enhance the amplification of reactive oxygen species. As iron enters and exits the brain via transport proteins in the blood-brain barrier (BBB), these proteins may represent candidates for a genetic susceptibility to PD. P-glycoprotein (P-gp) is one important efflux pump in the BBB. There is evidence that the function of P-gp is impaired in PD patients. In the current study we examined ten coding single nucleotide polymorphisms in the multidrug resistance gene 1 (MDR1) encoding P-gp to assess whether certain genotypes are associated with PD. However, genotyping of 300 PD patients and 302 healthy controls did not reveal a significant association between coding MDR1 gene polymorphisms and PD.

摘要

帕金森病(PD)的特征是多巴胺能神经元的丧失和胞质内包涵体(路易小体)的存在。铁在PD患者的黑质中含量升高,由于其增强活性氧物种放大的能力,似乎具有关键重要性。由于铁通过血脑屏障(BBB)中的转运蛋白进出大脑,这些蛋白可能代表PD遗传易感性的候选因素。P-糖蛋白(P-gp)是BBB中的一种重要外排泵。有证据表明PD患者中P-gp的功能受损。在本研究中,我们检测了编码P-gp的多药耐药基因1(MDR1)中的十个编码单核苷酸多态性,以评估某些基因型是否与PD相关。然而,对300例PD患者和302例健康对照的基因分型并未揭示编码MDR1基因多态性与PD之间存在显著关联。

相似文献

1
Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.欧洲帕金森病患者血脑屏障转运体MDR1编码单核苷酸多态性的基因分析。
J Neural Transm (Vienna). 2009 Apr;116(4):443-50. doi: 10.1007/s00702-009-0196-y. Epub 2009 Mar 3.
2
MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese.多药耐药蛋白1(MDR1),即血脑屏障转运蛋白,与华裔帕金森病有关。
J Med Genet. 2004 May;41(5):e60. doi: 10.1136/jmg.2003.013003.
3
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.血脑屏障成分P-糖蛋白(MDR1)的表达多态性与帕金森病的关系
Pharmacogenetics. 2002 Oct;12(7):529-34. doi: 10.1097/00008571-200210000-00004.
4
Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.德国帕金森病患者中血红素加氧酶-1(HO-1)的基因分析。
J Neural Transm (Vienna). 2009 Jul;116(7):853-9. doi: 10.1007/s00702-009-0237-6. Epub 2009 May 28.
5
MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.MDR1 C3435T 多态性与环境因素相互作用对帕金森病发病风险的影响:日本的一项病例对照研究。
Drug Metab Pharmacokinet. 2013;28(2):138-43. doi: 10.2133/dmpk.dmpk-12-rg-075. Epub 2012 Sep 11.
6
Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.表皮生长因子受体基因多态性与帕金森病易感性的关联。
Neurosci Lett. 2020 Sep 25;736:135273. doi: 10.1016/j.neulet.2020.135273. Epub 2020 Jul 24.
7
Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.细胞色素P450 2E1基因多态性/单倍型与瑞典人群中的帕金森病
J Neural Transm (Vienna). 2009 May;116(5):567-73. doi: 10.1007/s00702-009-0221-1. Epub 2009 Apr 21.
8
ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.结直肠癌中ABCB1基因多态性与单倍型分析
Int J Colorectal Dis. 2009 Aug;24(8):895-905. doi: 10.1007/s00384-009-0724-0. Epub 2009 May 5.
9
Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.比较 HIV 阳性和 HIV 阴性人群中 MDR1(ABCB1)单倍型结构和遗传多样性。
Infect Genet Evol. 2010 Jan;10(1):60-7. doi: 10.1016/j.meegid.2009.09.018. Epub 2009 Oct 9.
10
MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?多药耐药基因1(MDR1)变异与帕金森病风险。与接触杀虫剂有关吗?
J Neurol. 2009 Jan;256(1):115-20. doi: 10.1007/s00415-009-0089-x. Epub 2009 Jan 29.

引用本文的文献

1
Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease.炎症基因与帕金森病风险的定量和因果分析。
Front Immunol. 2023 Feb 28;14:1119315. doi: 10.3389/fimmu.2023.1119315. eCollection 2023.
2
Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis.一氧化氮合酶1(NOS1)外显子18、一氧化氮合酶1外显子29、三磷酸腺苷结合盒转运蛋白B1(ABCB1)1236C/T及ABCB1 3435C/T基因多态性与帕金森病风险的遗传关联:一项荟萃分析。
Medicine (Baltimore). 2016 Oct;95(40):e4982. doi: 10.1097/MD.0000000000004982.
3
Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

本文引用的文献

1
Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease.血脑屏障P-糖蛋白功能在早期帕金森病中未受损。
Parkinsonism Relat Disord. 2008 Aug;14(6):505-8. doi: 10.1016/j.parkreldis.2007.11.007. Epub 2008 Mar 5.
2
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.帕金森病、进行性核上性麻痹和多系统萎缩进展过程中血脑屏障P-糖蛋白功能降低。
J Neural Transm (Vienna). 2008 Jul;115(7):1001-9. doi: 10.1007/s00702-008-0030-y. Epub 2008 Feb 12.
3
Iron trafficking inside the brain.
ABCB1基因变异性、职业性农药暴露与帕金森病
Environ Res. 2015 Nov;143(Pt A):98-106. doi: 10.1016/j.envres.2015.08.022. Epub 2015 Oct 19.
4
Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.阿尔茨海默病与ABC转运蛋白——诊断与治疗的新机遇
Neurobiol Dis. 2014 Dec;72 Pt A:54-60. doi: 10.1016/j.nbd.2014.04.001. Epub 2014 Apr 16.
5
Glutathione metabolism and Parkinson's disease.谷胱甘肽代谢与帕金森病。
Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8.
大脑内的铁运输
J Neurochem. 2007 Dec;103(5):1730-40. doi: 10.1111/j.1471-4159.2007.04976.x. Epub 2007 Oct 22.
4
Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.载体介导的转运系统对血脑屏障作为大脑支持和保护界面的作用;对中枢神经系统药物发现与开发的重要性。
Pharm Res. 2007 Sep;24(9):1745-58. doi: 10.1007/s11095-007-9374-5. Epub 2007 Jul 10.
5
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.帕金森病的病因发病机制及未来研究建议。第一部分。
J Neuropathol Exp Neurol. 2007 Apr;66(4):251-7. doi: 10.1097/nen.0b013e3180415e42.
6
Pathogenic mutations in Parkinson disease.帕金森病中的致病突变
Hum Mutat. 2007 Jul;28(7):641-53. doi: 10.1002/humu.20507.
7
Brain iron metabolism.脑铁代谢
Semin Pediatr Neurol. 2006 Sep;13(3):142-8. doi: 10.1016/j.spen.2006.08.002.
8
Transcranial sonography in the early and differential diagnosis of Parkinson's disease.经颅超声检查在帕金森病早期诊断及鉴别诊断中的应用
J Neural Transm Suppl. 2006(70):249-54. doi: 10.1007/978-3-211-45295-0_38.
9
Recessive Parkinson's disease.隐性帕金森病
Mov Disord. 2006 Jul;21(7):885-93. doi: 10.1002/mds.20841.
10
Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.帕金森病中铁代谢紊乱——超声检查作为一种生物标志物
Neurotox Res. 2006 Jan;9(1):1-13. doi: 10.1007/BF03033302.